Tag:
Neupogen
Latest Headlines
Latest Headlines
Amgen founding CEO George Rathmann dies at 84
In the years after he took the helm of the company, Rathmann helped steer the development of Epogen and Neupogen. Only now does Amgen face rivals to its anemia franchise.
Fake Avastin may not be the only counterfeit on doctors' shelves
As doctors search their shelves for the counterfeit Avastin flagged by Roche ( $RHHBY ) and the FDA yesterday, officials are also hunting down illegally imported, unauthorized versions of other pricey
Hospira gains EMA OK for Neupogen biosimilar
Hospira says that it won European approval for its follow-on therapy to Amgen's blockbuster Neupogen. In winning the OK, Hospira provided late-stage data demonstrating that its therapy, Nivestim
Amgen joins the Teva-fighting club
Teva Pharmaceutical Industries has officially become a thorn in Amgen's side. The Israeli generics giant has asked FDA to approve its biotech drug designed to increase white blood cells in cancer
Analysts: Amgen most at risk from biogenerics
No drugmaker stands to lose more to biotech copycat drugs than Amgen. Analysts think its blockbuster blood-cell boosters Epogen and Neupogen will be among the first drugs copied in the U.S., once
